CAS: 2733573-94-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | (R)-N-(3-(2-Chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide REF: IN-DA02E6F9CAS: 2733573-94-7 | 95%+ | A consultar | Mar 07 Ene 25 |
 | RLY-2608 REF: TM-T81264CAS: 2733573-94-7 | 98.7% - 98.96% | 502,00 €~4.361,00 € | Mié 08 Ene 25 |
(R)-N-(3-(2-Chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxoisoindolin-4-yl)-3-fluoro-5-(trifluoromethyl)benzamide
CAS:2733573-94-7
Fórmula:
C29H14ClF5N6O2
Pureza:
95%+
Forma y color:
Solid
Peso molecular:
608.9055
Ref: IN-DA02E6F9
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
RLY-2608
CAS:2733573-94-7
RLY-2608 is a variant PI3Kalpha inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft …
Fórmula:
C29H14ClF5N6O2
Pureza:
98.7% - 98.96%
Forma y color:
Liquid
Peso molecular:
608.91
Ref: TM-T81264
| 1mg | 502,00 € | ||
| 5mg | 997,00 € | ||
| 10mg | 1.612,00 € | ||
| 25mg | 2.404,00 € | ||
| 50mg | 3.243,00 € | ||
| 1mL*10mM (DMSO) | 1.331,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
